Search
for
Sort by
Research 121–150 of 1000+
- New Modalities in the Treatment of Refractory Alopecia Areata
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- A mouse model of vitiligo based on endogenous auto-reactive CD8 + T cell targeting skin melanocyte
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Inheritance-Specific Dysregulation of Th1- and Th17-Associated Cytokines in Alopecia Areata
- Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance
- Genome-wide association study of atopic and autoimmune comorbidities in alopecia areata
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Recent advances in the genetics of alopecia areata
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Immune therapies for alopecia areata: evidence and new perspectives
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- An Updated in the Management of Alopecia Areata
- Sexual Dysfunction in Alopecia Areata: A Systematic Review
- Stem Cells as a Target for the Delivery of Active Molecules to Skin by Topical Administration
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Efficacy and Safety of Platelet-Rich Plasma Therapy in Alopecia Areata Patients: A Systematic Review
- Integrated Meta-Analysis of Scalp Transcriptomics and Serum Proteomics Defines Alopecia Areata Subtypes and Core Disease Pathways
- Dermal Fibrosis and the Current Scope of Hydrogel Strategies for Scarless Wound Healing
- Decoding Gut Microbiome Dysbiosis as a Non-Invasive Diagnostic Biomarker for Alopecia Areata
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- Gut microbiome, metabolome and alopecia areata
- MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata
- Identification of SLC40A1, LCN2, CREB5, and SLC7A11 as ferroptosis-related biomarkers in alopecia areata through machine learning
- Potential Therapeutic Applications of Bee Venom on Skin Disease and Its Mechanisms: A Literature Review